Mulmit

Janux Therapeutics, Inc.Janux Therapeutics, Inc.

JANX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3110,000,000-157,667,000-113,625,000-1.83
2024-12-3110,588,000-98,847,000-68,994,000-1.28
2023-12-318,083,000-72,979,000-58,293,000-1.32
2022-12-318,612,000-67,091,000-63,059,000-1.52
2021-12-313,637,000-32,929,000-32,672,000-1.39

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-31Campbell David AlanPresident and CEO123,840
2026-07-08Campbell David AlanPresident and CEO7,000
2026-07-08Campbell David AlanPresident and CEO7,000
2026-06-11Simson Jake5,500
2026-06-11Simson Jake15,500
2026-06-11Hernday Natasha5,500
2026-06-11Hernday Natasha15,500
2026-06-11Kung Winston5,500
2026-06-11Kung Winston15,500
2026-06-11Barrett Ronald W5,500
2026-06-11Barrett Ronald W15,500
2026-06-11CAPPS VICKIE L5,500

8-K events

FiledItems
2026-08-06Results of operations · Financial statements and exhibits
2026-06-23Other events
2026-06-12Submission of matters to a vote
2026-05-07Results of operations · Financial statements and exhibits
2026-04-28Officer or director change
2026-02-26Results of operations · Financial statements and exhibits
2026-01-22Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2025-11-06Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.

한국 시장 대시보드Korea dashboard 미국·글로벌 대시보드US & Global dashboard